These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 26797565)

  • 1. Non-invasive Imaging of Idiopathic Pulmonary Fibrosis Using Cathepsin Protease Probes.
    Withana NP; Ma X; McGuire HM; Verdoes M; van der Linden WA; Ofori LO; Zhang R; Li H; Sanman LE; Wei K; Yao S; Wu P; Li F; Huang H; Xu Z; Wolters PJ; Rosen GD; Collard HR; Zhu Z; Cheng Z; Bogyo M
    Sci Rep; 2016 Jan; 6():19755. PubMed ID: 26797565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-Modality Activity-Based Probes as Molecular Imaging Agents for Vascular Inflammation.
    Withana NP; Saito T; Ma X; Garland M; Liu C; Kosuge H; Amsallem M; Verdoes M; Ofori LO; Fischbein M; Arakawa M; Cheng Z; McConnell MV; Bogyo M
    J Nucl Med; 2016 Oct; 57(10):1583-1590. PubMed ID: 27199363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type I collagen-targeted PET probe for pulmonary fibrosis detection and staging in preclinical models.
    Désogère P; Tapias LF; Hariri LP; Rotile NJ; Rietz TA; Probst CK; Blasi F; Day H; Mino-Kenudson M; Weinreb P; Violette SM; Fuchs BC; Tager AM; Lanuti M; Caravan P
    Sci Transl Med; 2017 Apr; 9(384):. PubMed ID: 28381537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive imaging of cysteine cathepsin activity in solid tumors using a 64Cu-labeled activity-based probe.
    Ren G; Blum G; Verdoes M; Liu H; Syed S; Edgington LE; Gheysens O; Miao Z; Jiang H; Gambhir SS; Bogyo M; Cheng Z
    PLoS One; 2011; 6(11):e28029. PubMed ID: 22132198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophages: friend or foe in idiopathic pulmonary fibrosis?
    Zhang L; Wang Y; Wu G; Xiong W; Gu W; Wang CY
    Respir Res; 2018 Sep; 19(1):170. PubMed ID: 30189872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine Receptor 2-targeted Molecular Imaging in Pulmonary Fibrosis. A Clinical Trial.
    Brody SL; Gunsten SP; Luehmann HP; Sultan DH; Hoelscher M; Heo GS; Pan J; Koenitzer JR; Lee EC; Huang T; Mpoy C; Guo S; Laforest R; Salter A; Russell TD; Shifren A; Combadiere C; Lavine KJ; Kreisel D; Humphreys BD; Rogers BE; Gierada DS; Byers DE; Gropler RJ; Chen DL; Atkinson JJ; Liu Y
    Am J Respir Crit Care Med; 2021 Jan; 203(1):78-89. PubMed ID: 32673071
    [No Abstract]   [Full Text] [Related]  

  • 7. MicroSPECT Imaging-Guided Treatment of Idiopathic Pulmonary Fibrosis in Mice with a Vimentin-Targeting
    Zhang D; Zhuang R; Li J; Lv Y; Yang X; Pan W; Zhang X
    Mol Pharm; 2021 Nov; 18(11):4140-4147. PubMed ID: 34657437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of
    Hiroyama S; Matsunaga K; Ito M; Iimori H; Tajiri M; Nakano Y; Shimosegawa E; Abe K
    Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4358-4368. PubMed ID: 35876866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
    Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of the mouse model of acute exacerbation of idiopathic pulmonary fibrosis.
    Wei YR; Qiu H; Wu Q; Du YK; Yin ZF; Chen SS; Jin YP; Zhao MM; Wang C; Weng D; Li HP
    Exp Lung Res; 2016; 42(2):75-86. PubMed ID: 27070485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic pulmonary fibrosis: the role of pathobiology in making a definitive diagnosis.
    Padilla M
    Am J Manag Care; 2015 Oct; 21(14 Suppl):s276-83. PubMed ID: 26788615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease activated receptor-1 regulates macrophage-mediated cellular senescence: a risk for idiopathic pulmonary fibrosis.
    Lin C; Rezaee F; Waasdorp M; Shi K; van der Poll T; Borensztajn K; Spek CA
    Oncotarget; 2015 Nov; 6(34):35304-14. PubMed ID: 26474459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Pulmonary Fibrosis with a Collagen-Mimetic Peptide.
    Borgula IM; Shuvaev S; Abston E; Rotile NJ; Weigand-Whittier J; Zhou IY; Caravan P; Raines RT
    ACS Sens; 2023 Nov; 8(11):4008-4013. PubMed ID: 37930825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression.
    Yang G; Yang L; Wang W; Wang J; Wang J; Xu Z
    Gene; 2015 May; 562(1):138-44. PubMed ID: 25725128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical management of Idiopathic Pulmonary Fibrosis.
    Kishaba T
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jul; 32(2):90-8. PubMed ID: 26278687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis.
    Williamson JD; Sadofsky LR; Hart SP
    Exp Lung Res; 2015 Mar; 41(2):57-73. PubMed ID: 25514507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel segmental challenge model for bleomycin-induced pulmonary fibrosis in sheep.
    Organ L; Bacci B; Koumoundouros E; Barcham G; Kimpton W; Nowell CJ; Samuel C; Snibson K
    Exp Lung Res; 2015 Apr; 41(3):115-34. PubMed ID: 25531791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis.
    Kim TH; Lee YH; Kim KH; Lee SH; Cha JY; Shin EK; Jung S; Jang AS; Park SW; Uh ST; Kim YH; Park JS; Sin HG; Youm W; Koh ES; Cho SY; Paik YK; Rhim TY; Park CS
    Am J Respir Crit Care Med; 2010 Sep; 182(5):633-42. PubMed ID: 20463180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis.
    François A; Gombault A; Villeret B; Alsaleh G; Fanny M; Gasse P; Adam SM; Crestani B; Sibilia J; Schneider P; Bahram S; Quesniaux V; Ryffel B; Wachsmann D; Gottenberg JE; Couillin I
    J Autoimmun; 2015 Jan; 56():1-11. PubMed ID: 25441030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Danger-associated molecular patterns and danger signals in idiopathic pulmonary fibrosis.
    Ellson CD; Dunmore R; Hogaboam CM; Sleeman MA; Murray LA
    Am J Respir Cell Mol Biol; 2014 Aug; 51(2):163-8. PubMed ID: 24749648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.